More ImpediMed Limited news
ImpediMed LimitedASX: IPD

NSW Health Expands SOZO Use for Lymphoedema Prevention

Apr 20, 2020 at 11:40 PM EDT · Issued by ImpediMed Limited

Filed with ASX · Apr 20, 2020 at 11:40 PM EDT · 2 pages · English

On 6ix: 6ix.com/news/nsw-health-expands-sozo-use-for-lymphoedema-prevention

Watch ImpediMed's latest call↗ImpediMed (ASX:IPD) Q1 2027 Earnings Call · Replay · Oct 29Read the transcript of ImpediMed (ASX:IPD) Q1 2027 Earnings Call↗

ImpediMed Limited on 6ix

Story so far

  • New National Purchasing Agreement for Lymphoedema PreventionMar 23, 2020
  • Baylor Scott & White Expands SOZO Use with New iOS SoftwareMar 20, 2020
  • Lymphoedema Prevention Program AnnouncedOct 23, 2019

Earlier from ImpediMed

  • Independent BIS RE-AIM Analysis to be Released at ASCO 2020Apr 19, 2020
  • Change in substantial holdingApr 16, 2020
  • Appendix 4C - Quarter ended 31 March 2020Apr 15, 2020
  • ImpediMed Releases Heart Failure and Renal Disease SoftwareApr 14, 2020
  • Successful Completion of $10m Institutional Portion of OfferApr 2, 2020

Later from ImpediMed

  • Completion of Retail Entitlement OfferApr 27, 2020
  • ImpediMed Secures US Government COVID-19 CARES Act LoanMay 6, 2020
  • Response to ASX Price QueryMay 22, 2020
  • Scripps Collaboration Preps SOZO for Heart Failure LaunchJul 22, 2020
  • Appendix 4C - Quarter ended 30 June 2020Jul 27, 2020
All ImpediMed news releases↗

Follow ImpediMed into a list and get an email when it puts out news.

Follow ImpediMed
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer